FRET Antibody Pair for Rapid Staphylococcus aureus Enterotoxin A Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current immunoassays for detecting specific target molecules, such as Staphylococcus aureus Enterotoxin A, lack sensitivity and specificity, and require complex procedures, making them inadequate for rapid and effective food safety monitoring and diagnostics.
Innovation Solution
A Förster resonance energy transfer (FRET) based method using recombinant antibodies or antigen binding fragments that form a FRET pair when binding to Staphylococcus aureus Enterotoxin A, enabling a simple, rapid, and sensitive one-step immunoassay without the need for sample pretreatment, suitable for various sample types including food and environmental samples.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional immunoassays are used for detecting Staphylococcus aureus Enterotoxin A, then detection can be performed, but sensitivity and specificity are insufficient and procedures are complex
Solution Approach 1:
The patent replaces conventional mechanical/chemical immunoassay detection systems with a FRET-based optical detection system. By using fluorescently labeled antibodies that emit energy transfer signals when bound to the target toxin, the assay achieves higher sensitivity and specificity while simplifying the detection mechanism through optical signal transduction rather than complex chemical reactions
Solution Approach 2:
The patent changes the detection parameter from conventional colorimetric or chemiluminescent signals to FRET optical signals. This parameter change enables more precise measurement of toxin presence and concentration, improving detection sensitivity while allowing for automated optical readout that reduces procedural complexity
2Productivity
If conventional immunoassays are used for detecting Staphylococcus aureus Enterotoxin A, then detection can be performed, but the procedure is complex and time-consuming
Solution Approach 1:
The patent employs pre-formulated FRET pairs consisting of fluorescently labeled antibodies designed to work together in a single-step detection system. These pre-prepared reagent combinations eliminate the need for multiple sequential steps including separate labeling procedures and intermediate reactions, thereby accelerating detection while maintaining simplicity
Solution Approach 2:
The patent merges multiple detection functions into a single FRET-based measurement step. By combining the binding detection and signal generation into one integrated process using fluorescently labeled antibody pairs, the assay achieves rapid results without requiring separate detection steps, thus improving productivity while reducing complexity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The FRET method allows for the rapid detection of Staphylococcus aureus Enterotoxin A in samples within 5-10 minutes, providing effective and sensitive results, suitable for high-throughput analysis and ensuring food safety by enabling quick decision-making in food processing and healthcare settings.
Implementation Method 1
A very specific immunoassay can be obtained by the combination of antibodies or antigen binding fragments thereof and tools enabling a FRET reaction in the presence of a target antigen
Data Source
AI summary
The invention relates to a method for determining a target molecule in a sample. Also, the invention relates to a Förster resonance energy transfer (FRET, fluorescence resonance energy transfer) pair, recombinant antibodies, or antigen binding fragments thereof that bind Staphylococcus aureus Enterotoxin A and a test kit comprising the FRET pair, antibody or antigen binding fragment. Furthermore, the present invention relates to an isolated nucleic acid molecule comprising a nucleotide sequence that encodes the recombinant antibody or antigen binding fragment, and an expression vector comprising said nucleic acid molecule. Still, the invention relates to use of the FRET pair or the recombinant antibody or an antigen binding fragment thereof for determining a target molecule such as Staphylococcus aureus Enterotoxin A in a sample. And still, the invention relates to a method of producing the antibody or antigen binding fragment.


